Eagle Pharmaceuticals (EGRX) PT Raised to $50 at Cantor Fitzgerald, Following Earnings
Tweet
Share
E-mailGet Alerts EGRX Hot Sheet
Price: $2.14 --0%
Rating Summary:
2 Buy, 2 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Rating Summary:
2 Buy, 2 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
Cantor Fitzgerald analyst Brandon Folkes raised the price target on Eagle Pharmaceuticals (NASDAQ: EGRX) to $50.00 (from $46.00) while maintaining a Neutral rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Enovix Corporation (ENVX) PT Lowered to $5 at BofA Securities
- Voltas Ltd. (VOLT:IN) PT Lowered to INR1,357 at Nomura/Instinet
- JD Health International Inc (6618:HK) PT Lowered to HK$60 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Cantor Fitzgerald, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
